227939-01-7

Basic information

• Product Name: (5-BROMOPYRIDIN-2-YL)METHYL-CARBAMIC ACID TERT-BUTYL ESTER
• Synonyms: (5-BROMOPYRIDIN-2-YL)METHYL-CARBAMIC ACID TERT-BUTYL ESTER;2-(N-BOC-N-methylamino)-5-bromopyridine;N-Boc-N-methyl-5-bromo-2-pyridinamine;tert-Butyl (5-bromopyridin-2-yl)
• CAS NO: 227939-01-7
• Molecular Formula: C11H15BrN2O2
• Molecular Weight: 287.16
• Mol File: 227939-01-7.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 338.5°C at 760 mmHg
• Flash Point: 158.5°C
• Appearance: /
• Density: 1.391g/cm³
• Vapor Pressure: 9.8E-05mmHg at 25°C
• Refractive Index: 1.558
• Storage Temp.: 2-8°C
• CAS DataBase Reference: (5-BROMOPYRIDIN-2-YL)METHYL-CARBAMIC ACID TERT-BUTYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: (5-BROMOPYRIDIN-2-YL)METHYL-CARBAMIC ACID TERT-BUTYL ESTER(227939-01-7)
• EPA Substance Registry System: (5-BROMOPYRIDIN-2-YL)METHYL-CARBAMIC ACID TERT-BUTYL ESTER(227939-01-7)

Safety Data

• Hazardous Substances Data: 227939-01-7(Hazardous Substances Data)

Usage

General Description

(5-Bromopyridin-2-yl)methyl-carbamic acid tert-butyl ester is a chemical compound with the molecular formula C11H14BrN3O2. It is a carbamate ester, which is commonly used as a protective group for amines in organic synthesis. The presence of the bromine group makes this compound useful for various chemical reactions, including nucleophilic substitution and palladium-catalyzed coupling reactions. This chemical has potential applications in the pharmaceutical industry as a building block for the synthesis of biologically active compounds. Additionally, its tert-butyl ester group provides stability and protection for the reactive carbamate functionality, making it a valuable tool in organic chemistry.

InChI:InChI=1/C11H15BrN2O2/c1-11(2,3)16-10(15)14(4)9-6-5-8(12)7-13-9/h5-7H,1-4H3

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 624-28-2 2,5-dibromopyridine 
• 84539-30-0 5-bromo-N-methylpyridin-2-amine 
• 1072-97-5 5-bromo-2-pyridylamine 
• 74-88-4 methyl iodide 
• 159451-66-8 tert-butyl N-(5-bromopyridin-2-yl)carbamate 

Downstream Products

• 1235449-52-1 N-hydroxy-2-(methyl((2-(6-(methylamino)pyridin-3-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)amino)pyrimidine-5-carboxamide 
• 1032758-87-4 methyl-[5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyridin-2-yl]-carbamic acid tert-butyl ester 

Relevant articles and documents

Diaromatic vinyl derivative as well as preparation method and application thereof

The structural formula of the diaromatic vinyl derivative is shown I. In-flight R1 Document CH3 (Methyl) or CD3 (Deuterated methyl). R2 A group selected from C1 - 8 saturated alkoxy or alkylamino, substituted C2

Thiophene pyrimidines and preparation and its preparation method and application

The invention discloses a pyrantel compound and preparation, as well as a preparation method and application of the pyrantel compound and preparation, belonging to the technical field of chemical medicines and preparations thereof. According to the pyrantel compound or pharmaceutically acceptable salt thereof, HDAC (histone deacetylase)/PI3K (phosphatidylinositide 3-kinase) double-target inhibitor is used for selectively inhibiting tumor cell messenger core protein kinase target PI3K and epigenetic target HDAC which are synergized, and is capable of destroying the network of tumor cell messengers, thus exerting a great killing effect on various tumor cells. In multiple blood and entity heterogenic transplanted tumor animal models, the inhibitor can be used for intensively effectively inhibiting tumor growth and especially has a remarkable effect on various blood B-cell malignant tumors, and safety evaluation tests indicate that the inhibitor has high safety and security. The pyrantel compound and preparation can be used for effectively treating patients with later reoccurrence of lymphoma, myeloma and lymphatic leukemia or drug resistance.

THIAZOLOPYRIMIDINE PI3K INHIBITOR COMPOUNDS AND METHODS OF USE

Compounds of Formulas (Ia and Ib), and including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting lipid kinases including PI3K, and for treating disorders such as cancer mediated by lipid kinases. Methods of using compounds of formula Ia and Ib for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed